Y Miki Selected Research

Y Miki Research Topics

Disease

4	Breast Neoplasms (Breast Cancer) 07/2013 - 03/2000
3	Neoplasms (Cancer) 08/2015 - 01/2001
3	Carcinoma (Carcinomatosis) 01/2013 - 03/2006
2	Neoplasm Metastasis (Metastasis) 10/2013 - 01/2001
1	Neuromyelitis Optica (Devic's Disease) 01/2018
1	Inflammation (Inflammations) 01/2016
1	Noninfiltrating Intraductal Carcinoma (DCIS) 07/2013
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 04/2013
1	Triple Negative Breast Neoplasms 01/2013
1	Adenocarcinoma 11/2012
1	Adenocarcinoma of Lung 11/2012
1	Prostatic Neoplasms (Prostate Cancer) 01/2012
1	Hypoglycemia (Reactive Hypoglycemia) 06/2011
1	Sarcoma (Soft Tissue Sarcoma) 07/2010
1	Diabetes Mellitus 12/2009
1	Type 2 Diabetes Mellitus (MODY) 12/2009
1	Hepatocellular Carcinoma (Hepatoma) 05/2008
1	Genomic Instability 05/2008
1	Gliosis 01/2007
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 12/2001
1	Aneurysm (Aneurysms) 05/2001
1	Atherosclerosis 01/2001
1	Hepatorenal form of glycogen storage disease 12/2000
1	Carcinogenesis 04/2000
1	Hyperinsulinism (Hyperinsulinemia) 01/2000
1	Ischemia 01/2000
1	Hyperammonemia 01/2000
1	Reperfusion Injury 01/2000
1	Congenital Hyperinsulinism 01/2000

Drug/Important Bio-Agent (IBA)

3	Biological ProductsIBA 01/2016 - 03/2006
2	Estrogen Receptor alphaIBA 07/2013 - 03/2006
2	Progesterone Receptors (Progesterone Receptor)IBA 07/2013 - 03/2006
2	AndrogensIBA 01/2013 - 01/2012
2	Estrogen ReceptorsIBA 01/2012 - 03/2006
1	Immunoglobulin G (IgG)IBA 01/2018
1	Aquaporin 4IBA 01/2018
1	Arachidonic Acid (Vitamin F)IBA 01/2016
1	Secretory Phospholipases A2IBA 01/2016
1	EnzymesIBA 01/2016
1	Docetaxel (Taxotere)FDA Link 10/2013
1	Tamoxifen FDA LinkGeneric 07/2013
1	Aromatase (CYP19)IBA 07/2013
1	Aromatase InhibitorsIBA 07/2013
1	Estrogens (Estrogen)FDA Link 07/2013
1	Letrozole (Femara)FDA LinkGeneric 07/2013
1	Steryl-Sulfatase (Steroid Sulfatase)IBA 04/2013
1	Androgen Receptors (Androgen Receptor)IBA 01/2013
1	Biomarkers (Surrogate Marker)IBA 11/2012
1	Carcinoembryonic AntigenIBA 11/2012
1	Tyrosine Kinase InhibitorsIBA 11/2012
1	ErbB Receptors (EGF Receptor)IBA 11/2012
1	Cell Adhesion MoleculesIBA 11/2012
1	Gefitinib (Iressa)FDA Link 11/2012
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2012
1	Messenger RNA (mRNA)IBA 01/2012
1	LigandsIBA 01/2012
1	Transcription Factors (Transcription Factor)IBA 01/2012
1	Bombesin Receptors (Bombesin Receptor)IBA 01/2012
1	Insulin Glargine (Lantus)FDA Link 06/2011
1	Insulin Detemir (Levemir)FDA Link 06/2011
1	Isophane Insulin (NPH Insulin)FDA Link 06/2011
1	Nateglinide (Starlix)FDA LinkGeneric 12/2009
1	Hypoglycemic Agents (Hypoglycemics)IBA 12/2009
1	glimepiride (Amarel)FDA LinkGeneric 12/2009
1	Aurora Kinase BIBA 05/2008
1	Glial Fibrillary Acidic ProteinIBA 01/2007
1	PPAR gammaIBA 03/2006
1	Estrogen Receptor betaIBA 03/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 03/2006
1	Insulin (Novolin)FDA Link 12/2001
1	Hemoglobins (Hemoglobin)IBA 12/2001
1	ElementsIBA 05/2001
1	Pharmaceutical PreparationsIBA 01/2001
1	oxidized low density lipoproteinIBA 01/2001
1	Scavenger Receptors (Scavenger Receptor)IBA 01/2001
1	Chemotactic FactorsIBA 01/2001
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2001
1	Glucose-6-Phosphatase (Glucose 6 Phosphatase)IBA 12/2000
1	Codon (Codons)IBA 04/2000
1	Nonsense Codon (Nonsense Mutation)IBA 04/2000
1	BRCA2 ProteinIBA 04/2000
1	DNA (Deoxyribonucleic Acid)IBA 03/2000
1	Glutamate DehydrogenaseIBA 01/2000
1	antithrombin III-protease complexIBA 01/2000
1	Hyaluronic Acid (Hyaluronan)IBA 01/2000
1	ThrombomodulinIBA 01/2000

Therapy/Procedure

6	Therapeutics 08/2015 - 01/2001
1	Kidney Transplantation 08/2015
1	Radiotherapy 07/2010
1	Hepatectomy 05/2008
1	Glycemic Control 12/2001